DECREASE IN MYOCARDIAL RYANODINE RECEPTORS AND ALTERED EXCITATION-CONTRACTION COUPLING EARLY IN THE DEVELOPMENT OF HEART-FAILURE

被引:95
作者
VATNER, DE
SATE, N
KIUCHI, K
SHANNON, RP
VATNER, SF
机构
[1] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED,BOSTON,MA 02115
[2] BETH ISRAEL HOSP,DEPT MED,BOSTON,MA 02215
[3] MASSACHUSETTS GEN HOSP,CHILDRENS SERV,BOSTON,MA 02114
关键词
RECEPTORS; CALCIUM CHANNELS; PACING; HEART FAILURE;
D O I
10.1161/01.CIR.90.3.1423
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Rapid ventricular pacing for 1 day reduced myocardial contractile function without inducing heart failure in conscious, chronically instrumented dogs. After 4 to 7 weeks of pacing, myocardial contractility was depressed further and overt signs of congestive heart failure, eg, ascites, dyspnea, and edema, were evident. Methods and Results The mechanical restitution response, a physiological index of calcium release, was depressed at 1 day of rapid ventricular pacing. Postextrasystolic potentiation was also depressed by a similar amount, 14+/-3%, at 1 day after pacing. The response to isoproterenol 0.2 mu g/kg per minute was depressed by a significantly greater amount (P<.05), 52+/-7%, at 1 day after pacing. H-3-ryanodine receptor binding fell from 1013+/-25 to 808+/-42 fmol/mg after 1 day of pacing and remained depressed at similar levels (782+/-61 fmol/mg) at 4 to 7 weeks when heart failure was manifest. Ryanodine receptor affinity was unchanged from control values. Neither dihydropyridine binding nor affinity for H-3-PN200-110 was changed from control levels. Within 5 days after recovery from 1 day of pacing, physiological responses to isoproterenol, postextrasystolic potentiation, and mechanical restitution recovered, as did H-3-ryanodine binding density. Conclusions These findings suggest that the changes in excitation-contraction coupling and potentially the sarcoplasmic reticulum calcium release channel occur early in the development of heart failure and therefore may be important in the pathogenesis of the contractile abnormalities in this disease state.
引用
收藏
页码:1423 / 1430
页数:8
相关论文
共 36 条
[1]   DIFFERENTIAL CHANGES IN LEFT AND RIGHT VENTRICULAR SR CALCIUM-TRANSPORT IN CONGESTIVE-HEART-FAILURE [J].
AFZAL, N ;
DHALLA, NS .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (03) :H868-H874
[2]   THE INTERACTION OF CALCIUM AND RYANODINE WITH CARDIAC SARCOPLASMIC-RETICULUM [J].
ALDERSON, BH ;
FEHER, JJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1987, 900 (02) :221-229
[3]  
ANDERSON K, 1989, J BIOL CHEM, V264, P1329
[4]   FORCE INTERVAL RELATIONS OF TWITCHES AND COLD CONTRACTURES IN RAT CARDIAC TRABECULAE - EFFECT OF RYANODINE [J].
BANIJAMALI, HS ;
GAO, WD ;
MACINTOSH, BR ;
TERKEURS, HEDJ .
CIRCULATION RESEARCH, 1991, 69 (04) :937-948
[5]   DIFFERENCES IN CARDIAC CALCIUM RELEASE CHANNEL (RYANODINE RECEPTOR) EXPRESSION IN MYOCARDIUM FROM PATIENTS WITH END-STAGE HEART-FAILURE CAUSED BY ISCHEMIC VERSUS DILATED CARDIOMYOPATHY [J].
BRILLANTES, AM ;
ALLEN, P ;
TAKAHASHI, T ;
IZUMO, S ;
MARKS, AR .
CIRCULATION RESEARCH, 1992, 71 (01) :18-26
[6]   MECHANICAL RESTITUTION OF ISOLATED PERFUSED CANINE LEFT-VENTRICLES [J].
BURKHOFF, D ;
YUE, DT ;
FRANZ, MR ;
HUNTER, WC ;
SAGAWA, K .
AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 246 (01) :H8-H16
[7]   MECHANICAL RESTITUTION IN ISOLATED MAMMALIAN MYOCARDIUM - SPECIES-DIFFERENCES AND UNDERLYING MECHANISMS [J].
COOPER, IC ;
FRY, CH .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1990, 22 (04) :439-452
[8]   COMPENSATORY DOWN-REGULATION OF MYOCARDIAL CA CHANNEL IN SR FROM DOGS WITH HEART-FAILURE [J].
CORY, CR ;
MCCUTCHEON, LJ ;
OGRADY, M ;
PANG, AW ;
GEIGER, JD ;
OBRIEN, PJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (03) :H926-H937
[9]   CONTRACTILE PROPERTIES AND CA-2+ RELEASE ACTIVITY OF THE SARCOPLASMIC-RETICULUM IN DILATED CARDIOMYOPATHY [J].
DAGNOLO, A ;
LUCIANI, GB ;
MAZZUCCO, A ;
GALLUCCI, V ;
SALVIATI, G .
CIRCULATION, 1992, 85 (02) :518-525
[10]   RADIOLIGAND BINDING AND INOTROPIC EFFECTS OF RYANODINE IN THE CARDIOMYOPATHIC SYRIAN-HAMSTER [J].
FINKEL, MS ;
LI, S ;
ROMEO, RC ;
ODDIS, CV ;
SALAMA, G .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 (04) :610-617